HSBC Holdings
CGON icon

HSBC Holdings’s CG Oncology CGON Stock Holding History

HSBC Holdings’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.7M Buy
+187,765
New +$10.6M 0.01% 867
2024
Q4 		– Sell
-5,792
Closed -$222K – 3108
2024
Q3 		$222K Buy
+5,792
New +$203K ﹤0.01% 2546

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

HSBC Holdings's CGON Position: Q1 2026 in Review

HSBC Holdings opened a new position in CG Oncology (CGON) in Q1 2026: 187,765 shares worth $12.7M. The stake represents 0.01% of the portfolio and ranks #867 among its holdings. This is a return to the name: HSBC Holdings previously reported a position in CGON as recently as Q3 2024.

HSBC Holdings first reported a position in CGON in Q3 2024 and has held it in 2 quarters since. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • HSBC Holdings held 187,765 shares of CG Oncology worth $12.7M as of Q1 2026.
  • CG Oncology was a new HSBC Holdings position in Q1 2026.
  • CG Oncology made up 0.01% of HSBC Holdings's portfolio in Q1 2026, its #867 holding.
  • HSBC Holdings first reported a position in CG Oncology in Q3 2024 and has held it in 2 quarters since.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.